WARNING:
JavaScript is turned OFF. None of the links on this concept map will
work until it is reactivated.
If you need help turning JavaScript On, click here.
This Concept Map, created with IHMC CmapTools, has information related to: Rheumatoid Arthritis ACR v1, Therapeutic Efficacy Point is the intersection of Observation or Assessment, newly added concepts are denoted by green color outlines, Time Points instantiated_by - date - visit # - Week #, Concepts are denoted by solid round-edged rectangle, CM Details documented_at baseline, FDA EFFICACY CRITERIA FOR RHEUMATOID ARTHRITIS include Clinical response, FDA EFFICACY CRITERIA FOR RHEUMATOID ARTHRITIS include major covariates Rheumatoid Factor, Clinical response has_outcomes Disease Activity Score (DAS28), FDA EFFICACY CRITERIA FOR RHEUMATOID ARTHRITIS include major covariates Geographic Region, Physical Function measured_at Time Points, FDA EFFICACY CRITERIA FOR RHEUMATOID ARTHRITIS include Radiographic Response, Time Points instantiated_by - date - visit # - Week #, ???? has attribute / option imputed flag, Health Related Quality Of Life (HRQOL) has outcome assessment Short Form (SF-36), MTX instantiated_by Yes/No, Swollen joint count instantiated_by - Present - Absent - Not Done - N/A, Oral Disease-modifying antirheumatic drug instantiated_by Yes/No, FDA EFFICACY CRITERIA FOR RHEUMATOID ARTHRITIS include major covariates Anti-cyclic Citrullinated Peptide, Physical Function has outcome assessment Health Assessment Questionnaire - Disability Index (HAQ-DI), Oral corticosteroids instantiated_by Yes/No